National HealthCare Corporation (NHC) Aandelenanalyse

Bedrijfsoverzicht

National HealthCare Corporation is primarily engaged in the operation of services for skilled nursing facilities, assisted and independent living facilities, homecare, hospice agencies, and health hospitals, operating through distinct inpatient and homecare segments. The company functions within the healthcare sector, specifically inside the medical care facilities industry, which implies a focus on providing essential medical support and long-term care infrastructure. Its scale is substantial, with a market capitalization of $2.67B and an annual revenue of $1.52B generated by a workforce of 15278 employees. These valuation and revenue figures indicate that the organization holds a significant position in the market, reflecting a large asset base and a capacity to serve a broad customer base across various healthcare delivery models. The size of the entity, evidenced by its revenue and employee count, suggests a mature operation capable of sustaining extensive service networks.

Financiële gezondheid

The company reported a revenue of $1.52B and a net income of $120.02M for the trailing twelve months, with an EBITDA of $173.27M. The substantial gap between the total revenue and the net income reveals a cost structure where operational expenses, including taxes and interest, consume a significant portion of gross earnings, resulting in a profit margin of 7.9%. Free cash flow stands at $108.38M, which indicates that the company generates sufficient cash after capital expenditures to maintain financial flexibility for debt repayment or potential acquisitions. Regarding liquidity and leverage, the firm holds $255.80M in cash against $87.07M in debt, creating a robust cushion where cash significantly exceeds total obligations. This balance sheet posture is further supported by a current ratio of 1.82, which indicates strong short-term liquidity and the ability to meet immediate financial obligations without distress. The capital structure is characterized by a debt-to-equity ratio of 8.10, suggesting a leveraged approach to financing, though the high cash reserves mitigate immediate risk. Management effectiveness is highlighted by a return on equity of 11.9% and a return on assets of 5.3%, metrics that demonstrate efficient utilization of shareholder capital and total assets to generate returns.

Waarderingsbeoordeling

The stock trades with a trailing P/E ratio of 22.28 and a forward P/E of 397.33, implying that the market expects a significant expansion in earnings or that current earnings are temporarily suppressed by one-time costs or restructuring charges. The forward P/E is notably higher than the trailing P/E, which suggests that analysts anticipate a sharp increase in future profitability relative to current performance levels. In terms of asset valuation, the price-to-book ratio is 2.48, indicating that the market prices the company at a premium of roughly 148% over its book value, reflecting intangible assets or future growth potential not captured on the balance sheet. Alternative valuation metrics such as a price-to-sales ratio of 1.76 and an EV/EBITDA of 14.38 suggest that investors are willing to pay a moderate multiple for revenue and earnings, consistent with the healthcare industry standards. The stock price has fluctuated between a 52-week high of $177.47 and a 52-week low of $89.40, providing a historical range for investors to assess current positioning. The beta value of 0.59 indicates that the stock exhibits low volatility relative to the broader market, moving less than half as much as the S&P 500 in typical market conditions.

Growth & Income

Revenue growth year-over-year is recorded at 4.6%, while earnings growth year-over-year reaches 306.3%, indicating that earnings are expanding at a rate far faster than revenue, likely due to margin expansion or non-recurring income recognition. For dividend investors, the company offers a dividend yield of 1.5% with a payout ratio of 33.0%, suggesting that the dividend is sustainable given the current earnings levels and the ability to retain a majority of profits for reinvestment. The combination of accelerating earnings growth and a conservative payout ratio creates a profile that balances income generation with capital retention for future operations. Overall, the company presents a growth and income profile characterized by double-digit earnings expansion and a steady but modest dividend return to shareholders.